These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11102247)

  • 1. A cold start for oral glycoprotein IIb/IIIa antagonists.
    Curtin R; Fitzgerald DJ
    Eur Heart J; 2000 Dec; 21(24):1992-4. PubMed ID: 11102247
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
    Akkerhuis KM; Neuhaus KL; Wilcox RG; Vahanian A; Boland JL; Hoffmann J; Baardman T; Nehmiz G; Roth U; Klootwijk AP; Deckers JW; Simoons ML;
    Eur Heart J; 2000 Dec; 21(24):2042-55. PubMed ID: 11102255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.
    Ageno W; Turpie AG
    G Ital Cardiol; 1999 Nov; 29(11):1357-65. PubMed ID: 10609142
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet agents in ischemic heart disease.
    May CH; Lincoff AM
    Handb Exp Pharmacol; 2012; (210):495-518. PubMed ID: 22918744
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology.
    Tcheng JE
    Thromb Haemost; 1997 Jul; 78(1):205-9. PubMed ID: 9198154
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet GP IIb/IIIa inhibition in unstable angina and non-ST segment elevation MI: application of the ACC/AHA guidelines.
    Young JJ; Choo JK; Kereiakes DJ; ;
    J Invasive Cardiol; 2003 Feb; 15(2):102-7; quiz 108. PubMed ID: 12556626
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 10. Decision making with cardiac troponin tests.
    Antman EM
    N Engl J Med; 2002 Jun; 346(26):2079-82. PubMed ID: 12087146
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
    Giannitsis E; Katus HA
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
    [No Abstract]   [Full Text] [Related]  

  • 12. IIb/IIIa Receptor Blockers. Preface.
    van den Brand M; O'Neill W
    Semin Interv Cardiol; 1999 Jun; 4(2):59-60. PubMed ID: 10473873
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Quinn MJ; Moliterno DJ
    Minerva Cardioangiol; 2002 Oct; 50(5):547-53. PubMed ID: 12384636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
    Umman B
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein inhibitors in patients with medically managed acute coronary syndrome: does the enthusiasm exceed the science?
    Schriger DL; Herbert ME
    Ann Emerg Med; 2001 Sep; 38(3):249-55. PubMed ID: 11524643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 18. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.